Bausch + Lomb Upgrades Full-Year Outlook on Strong Quarter
The eye health company raised its full-year guidance across the board, bumping its revenue target up by $20 million to a new range of $5.44 billion to $5.54 billion.
The eye health company raised its full-year guidance across the board, bumping its revenue target up by $20 million to a new range of $5.44 billion to $5.54 billion.